Polpharma
Pharma
Also written as: Polpharma Group, Polpharma S.A.
Data as of 4 Oct 2026
Markdown version
Markdown version
Polpharma was mentioned 15 times in 2 outlets over the last 12 months. Positive (7%) and negative (0%) coverage were close.
MENTIONS · 12M
15
22 all-time
OUTLETS · 12M
2
in 2 countries
AVG SENTIMENT
+0.064
Recent coverage
CMS advises Polpharma on landmark acquisition of Biofarm through voluntary takeover bid - CMS.law
cms.law · RO · 21 Jul 2026 · positive
Polpharma Biologics, Tuteur ink deal for autoimmune diseases biosimilar - Drug Store News
· US · 1 Jun 2026 · neutral
Polpharma Biologics And Tuteur Sign Landmark LATAM Biosimilar Licensing Partnership - BioPharma APAC
· US · 24 May 2026 · neutral
Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases - Business Wire
· US · 22 May 2026 · neutral
Largest Polish pharma group Polpharma to take over Romania’s Biofarm at EUR 270 mln valuation - Romania Insider
· US · 7 May 2026 · neutral
Polpharma SA Pharmaceutical Works proposed to acquire Biofarm S.A. from Longshield Investment Group SA, Lion Capital S.A. and other shareholders for RON 1.4 billion. - marketscreener.com
· US · 5 May 2026 · neutral
Striving for operational resiliency, Polpharma implements analytics at scale - KPMG
· US · 30 Apr 2026 · neutral
Russian drugmaker Binnopharm hopes to gain control over Polpharma’s Akrikhin - The Pharma Letter
· US · 14 Apr 2026 · neutral
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 1 |
| 2025-12 | 2 |
| 2026-01 | 0 |
| 2026-02 | 1 |
| 2026-03 | 1 |
| 2026-04 | 2 |
| 2026-05 | 4 |
| 2026-06 | 1 |
| 2026-07 | 1 |
| 2026-08 | 0 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Polpharma against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page